Want to see AUTL full AI Analyst Report?
Autolus Therapeutics (AUTL) Income Statement
Autolus Therapeutics Income Statement
Last quarter (Q2 2026), Autolus Therapeutics's total revenue was $45.69M, an increase of 118.37% from the same quarter last year. In Q2, Autolus Therapeutics's net income was $-39.11M. See Autolus Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 75.56M | $ 10.12M | $ 1.70M | $ 6.19M | $ 1.51M | |
| $ -21.03M | $ -130.90M | $ 1.70M | $ 6.19M | $ 1.51M | |
| $ 260.41M | $ 110.53M | $ 181.40M | $ 149.09M | $ 141.88M | |
| Depreciation and Amortization | $ 9.81M | $ 7.72M | $ 6.57M | $ 7.42M | $ 8.46M |
| $ -250.28M | $ -233.07M | $ -156.77M | $ -132.24M | $ -132.47M | |
| $ -281.44M | $ -241.43M | $ -179.70M | $ -142.89M | $ -140.37M | |
| $ -15.41M | $ 22.29M | $ -28.70M | $ -5.67M | $ -1.66M | |
| $ -296.85M | $ -219.13M | $ -208.40M | $ -148.57M | $ -142.04M | |
| $ -288.20M | $ -220.66M | $ -208.38M | $ -148.84M | $ -142.10M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.08 | $ -0.87 | $ -1.20 | $ -1.57 | $ -1.97 |
| Diluted EPS | $ -1.08 | $ -0.87 | $ -1.20 | $ -1.57 | $ -1.97 |
| Weighted Average Shares Outstanding | 266.14M | 255.16M | 173.94M | 94.99M | 72.08M |
| Weighted Average Shares Outstanding (Diluted) | 266.14M | 255.16M | 173.94M | 94.99M | 72.08M |
Currency in USD